NantHealth to Present at the Jefferies Healthcare Conference on June 7, 2017

CULVER CITY, Calif.--()--NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that the company will present at the Jefferies Healthcare Conference at 4 p.m. ET, on Wednesday, June 7, 2017 at the Grand Hyatt hotel, New York City.

“Adoption of Emerging Genomics Tools for Oncology in Clinical Diagnostics.”

The company also said that Patrick Soon-Shiong, M.D., chief executive officer and chairman of NantHealth, has been invited to participate in a panel discussion at the conference titled, “Adoption of Emerging Genomics Tools for Oncology in Clinical Diagnostics.” The panel discussion is scheduled for Wednesday, June 7, 2017, beginning at 9 a.m. ET.

A webcast of the presentation will be available at www.nanthealth.com. Listeners are encouraged to visit the web site at least 10 minutes prior to the start of the presentation to register, download and install any necessary software. The presentation will be archived and accessible on the web site for at least 90 days.

About NantHealth, Inc.

NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth's unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, NantHealth has developed an adaptive learning system, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time. For more information please visit www.nanthealth.com.

Contacts

NantHealth, Inc.
Robert Jaffe, 424.288.4098
rjaffe@rjaffeco.com

Recent Stories

RSS feed for NantHealth, Inc.

NantHealth, Inc.